Play all audios:
ABSTRACT This study utilized NHANES data from 2007 to 2018 to investigate the correlation between frailty and the Conicity Index (CI) in individuals aged 60 and above in the United States.
The study used NHANES data from 2007 to 2018.CI was calculated as CI = wc / [0.109 × sqrt(bw / Height)]. Frailty was assessed by the frailty index (≥ 0.25). Weighted multivariate logistic
regression analysis, subgroup analyses, and interaction tests were used to investigate the connection between CI and the prevalence of frailty. Generalized additive modeling (GAM) was
employed to address any non-linear patterns, and the predictive capability of CI for frailty was evaluated by receiver operating characteristic (ROC) analysis. With a 69% rise in the
prevalence of frailty for every 0.1 unit increase in the fully adjusted model, the results demonstrated a strong and positive relationship between CI and frailty prevalence (OR: 1.69, 95%
CI: 1.53,1.86; P < 0.001). When CI was categorized, the group with the highest CI had a significantly higher prevalence of frailty than the group with the lowest CI (OR = 2.79, 95% CI:
2.22,3.51; P < 0.001). The association between CI and prevalence of frailty was significant in all subgroups. In addition, statistically significant interactions were present in most
subgroups. When the CI > reached 1.35, the GAM model demonstrated a threshold effect and a significant nonlinear connection, with a 105% rise in the prevalence of frailty for every 0.1
unit increase in CI. In the male group, CI was a significantly greater indicator of the prevalence of frailty than both BMI and WC. According to this study, frailty in older persons is
substantially correlated with a higher CI. Although greater confirmation in large-scale prospective research is required, this study indicates that increased CI is a more reliable predictor
of the prevalence of frailty in older men and is significantly linked with its occurrence. SIMILAR CONTENT BEING VIEWED BY OTHERS COMBINED USE OF TWO FRAILTY TOOLS IN PREDICTING MORTALITY IN
OLDER ADULTS Article Open access 03 September 2022 IMPACT OF FRAILTY ON MORTALITY AND HEALTHCARE COSTS AND UTILIZATION AMONG OLDER ADULTS IN SOUTH KOREA Article Open access 01 December 2023
IS A HIGHER BODY MASS INDEX ASSOCIATED WITH LONGER DURATION OF SURVIVAL WITH DISABILITY IN FRAIL THAN IN NON-FRAIL OLDER ADULTS? Article Open access 15 November 2024 INTRODUCTION The state
of frailty, which is characterized by the deterioration of several physiological systems, greatly raises the risk of falls, incapacity, hospitalization, and even death1. As the global
population ages at an accelerated rate, frailty is becoming particularly prominent in the elderly population2. Understanding the metabolic basis of frailty is becoming increasingly important
to identify modifiable risk factors and develop targeted interventions3. It is commonly acknowledged that one of the main risk factors for frailty is obesity. However, traditional
assessments of body fat have mostly relied on metrics such as waist circumference (WC) or body mass index (BMI)4 but may have limitations when assessing the elderly population. These methods
do not accurately reflect the distribution of body fat, the distribution and quality of which may have a greater impact on the development of frailty5. The CI, a new obesity-related index,
is different from the traditional BMI in that CI combines weight, waist circumference, and height to more accurately reflect the distribution of fat, especially the effect of abdominal fat6.
According to previous research, CI exhibits high sensitivity in predicting risk for a number of illnesses, including metabolic diseases7, hypertension8, gallstones9, and urinary
incontinence in women10. In addition, studies have found a linear relationship between CI and mortality risk, suggesting that a high CI may increase mortality11, which further supports the
potential value of CI in health surveillance and risk assessment. While numerous studies have demonstrated a correlation between obesity and frailty, research addressing the relationship
between CI and frailty remains limited. Therefore, this study aims to improve our understanding of CI’s role in frailty screening and offer new support for early intervention in the elderly
population by evaluating its potential role in predicting frailty prevalence and examining its applicability in older U.S. adults using data from the National Health and Nutrition
Examination Survey (NHANES) from 2007 to 2018. MATERIALS AND METHODS DATABASE SOURCES AND SAMPLE SELECTION The NHANES is a nationwide cross-sectional research that assesses the general
health and nutritional status of noninstitutionalized U.S. adults using stratified multistage random sampling, which is carried out by the National Center for Health Statistics (NCHS).
Selected data from NHANES between 2007 and 2018 were used for the analysis of this study. First, information from 59,842 NHANES participants from 2007 to 2018 was taken into account. The
final sample consisted of 8,748 participants, excluding 47,932 persons younger than 60 years of age, 2,649 persons with unreliable frailty index assessments, 350 persons with missing or
outlier CI data, and 163 persons with missing covariates (Fig. 1). Informed consent forms were signed by all survey respondents, and the NHANES data were made publicly available. ASSESSMENT
OF FRAILTY A deficit accumulation model was used to measure frailty, and in order to be eligible, individuals had to answer at least 91% of the 49 questions on the Frailty Index (FI). The 49
diagnostic criteria that make up the FI encompass topics including cognitive function, physical performance, capacity to carry out everyday tasks, chronic illnesses, health status, and
laboratory testing. The final FI is calculated by dividing the total of the scores by the number of items12,13. Each criteria is rated based on severity, with 0 denoting no frailty and 1
denoting severe frailty. A FI value of 0.25 or greater than 14 is considered frail14. The complete set of criteria is given in Supplementary Table 1. ASSESSMENT OF CI Thorough training was
provided to all NHANES employees to guarantee measurement accuracy and uniformity. The exposure variable, CI, was computed as follows: CI = wc / [0.109 × sqrt(bw / Height)], with waist
circumference and height in meters, and body weight in kilograms6. Both continuous and categorical variables might be used to examine CI data. The CI values were analyzed by dividing them
into four groups (first quartile: 0.97 < CI ≤ 1.31; second quartile: 1.31 < CI ≤ 1.36; third quartile: 1.36 < CI ≤ 1.41; fourth quartile: 1.41 < CI ≤ 1.73). COVARIATES The study
controlled for a number of well-known covariates, such as age, gender, race, education level, marital status, PIR, diastolic and systolic blood pressure, energy intake, the Healthy Eating
Index 2015 (HEI-2015), smoking, alcohol use, and physical activity, in order to account for confounding variables. In addition, chronic diseases such as hypertension, high cholesterol,
diabetes, cardiovascular disease, chronic obstructive pulmonary disease (COPD), and chronic kidney disease (CKD) were also potential factors affecting frailty. PIR ≤ 1.3, 1.3 < PIR ≤ 3.5,
and PIR > 3.5 were used to classify specific income levels; smoking was defined as 100 cigarettes or more during one’s lifetime; and alcohol use was divided into five categories based on
current drinking status: never, former, heavy, moderate, and mild drinking15,16. Detailed categorization criteria are shown in Supplementary Table 2. Blood pressure was estimated by
averaging at least three consecutive standard measurements. Dietary information was gathered on the first day of the 24-h dietary recall trial. A person’s dietary compliance with the Dietary
Guidelines for Americans is assessed by the HEI-201517. Values vary from 0 to 100, with higher scores denoting higher-quality food and healthier eating practices. STATISTICAL ANALYSIS Each
statistical analysis took into account the complex sampling design of NHANES and applied the appropriate sampling weights. To avoid excessively large effect sizes, we created new data with a
tenfold CI for the analysis. Interpolated missing data for PIR, energy intake, HEI-2015, and alcohol use using the random forest method (missing values did not exceed 15%). Continuous
variables are shown as mean ± standard error (SE), whilst categorical data are presented as weighted percentages. Group differences were evaluated at baseline using t-tests and weighted
chi-square. The three weighted multivariate logistic regression models that were used to examine the relationship between CI and frailty were Model 1 (unadjusted), Model 2 (adjusted for age,
gender, race, and education level), and Model 3 (further adjusted for variables such as marital status, PIR, smoking, alcohol use, physical activity, SBP, DBP, HEI-2015, and energy intake).
While threshold effects and turning points were examined using linear regression models, potential nonlinear connections were assessed using GAM. Furthermore, interaction tests and subgroup
analysis have been performed out. ROC analysis was used to examine the predictive power of CI, BMI, and WC for frailty. DeLong tests were used to look for statistically significant changes
in the ROC analysis findings. Sensitivity analyses consisted, among other things, of removing all missing covariates and further adjusting for hypertension, high cholesterol, cardiovascular
disease, diabetes, COPD, CKD, cholesterol-lowering, and antidiabetic medication use. P-values below 0.05 were regarded as statistically significant. All statistical analyses were conducted
using Empower States (version 4.2) and R software (version 4.2). RESULTS BASELINE CHARACTERISTICS OF PARTICIPANTS Table 1 displays the overall demographics of the 8,748 participants in the
study, whose mean age was 69.48 ± 6.81 years.The sample was very well divided, with 49.94% of the participants being female and 50.06% being male. 13.57 ± 0.80 was the mean CI. As CI grew,
the prevalence of frailty rose noticeably. The basic characteristics of the groups differed significantly depending on whether they were frailty or not. MULTIPLE LOGISTIC REGRESSION ANALYSIS
Table 2 provides a summary of the weighted multivariate logistic regression analysis’s results. For every 0.1 unit increase in CI (95% CI: 1.66,2.00; P < 0.001), the prevalence of
frailty rose 1.82 times in model 1 (unadjusted); in model 2 (adjusted for age, sex, race, and education), the OR was 1.91 (95% CI: 1.73,2.11; P < 0.001). The prevalence of frailty
increased 69% in fully adjusted model 3 for every 0.1 unit rise in CI (OR: 1.69, 95% CI: 1.53,1.86; P < 0.001). Additionally, Table 2 shows that when CI was classified, the prevalence of
frailty was significantly higher in the group with the greatest CI than in the group with the lowest CI (OR = 2.79, 95% CI: 2.22,3.51; P < 0.001). NONLINEAR ANALYSIS The association
between CI and the prevalence of frailty was further assessed using GAM, and the findings showed a significant nonlinear connection (Fig. 2, Table 3). Segmented regression analysis provided
more evidence for the presence of a threshold effect. Furthermore, a threshold effect and a significant nonlinear association were seen in both males and females. SUBGROUP ANALYSIS Subgroup
analyses were carried out to investigate the association in various groups, accounting for factors such age, gender, race, education, marital status, BMI, PIR, BMI, HEI-2015, physical
activity, smoking, and alcohol use. Further supporting the idea that CI is a risk factor for frailty development in older Americans is the analysis’s findings, which revealed a significant
correlation between CI and the prevalence of frailty in all subgroups with statistically significant interactions in the majority of subgroups (Table 4). Results of the subgroup analysis
were adjusted for all covariates except the effect modifier. SENSITIVITY ANALYSIS A number of sensitivity analyses were performed to ensure the accuracy of the findings. These included
deleting all missing covariates and adjusting for hypertension, high cholesterol, diabetes, cardiovascular disease, COPD, CKD, cholesterol-lowering, and antidiabetic medication use. Good
stability of the data was indicated by the sensitivity analyses, which continuously revealed a substantial connection between CI and the prevalence of frailty (Table 5). ROC ANALYSIS ROC
analysis was used to evaluate the predictive power of CI, BMI, and WC for the prevalence of frailty. The findings indicated that the three did not significantly differ from the whole
population, and the predictive ability was poorly demonstrated in the female population. However, when it came to predicting the prevalence of frailty in the male population, CI performed
noticeably better than BMI and WC(Fig. 3, Table 6). DISCUSSION This study assessed the relationship between CI and frailty risk in US seniors aged 60 and above using NHANES data from
2007–2018. The results showed a significant and independent correlation between a higher prevalence of frailty and CI. Frailty prevalence increased by 69% for every 0.1 unit increase in CI
in fully adjusted models. The group with the greatest CI had a significantly higher prevalence of frailty than the group with the lowest CI (OR = 2.79, 95% CI: 2.22,3.51; P < 0.001).
Through GAM analysis, it was clarified that there was a nonlinear relationship between CI and frailty, with a 105% increase in frailty risk for every 0.1 unit increase in CI when CI >
1.35. CI considerably surpassed BMI and WC in predicting the prevalence of frailty in the male population, according to the results of the ROC curve study, which further demonstrated the
advantages of applying CI in differentiating high-risk populations. It should be noted that the absolute differences in AUC values among the three were relatively small. Therefore, the
clinical or practical significance of this difference remains unclear and needs to be further validated in larger samples and multicenter studies. The current results suggest that CI has
some potential as an indicator of abdominal fat distribution, but it is not yet sufficient to replace existing commonly used indicators, and future studies should focus on its practical
value in different populations and specific health outcomes. Subgroup and sensitivity analyses were also performed in this study to increase the robustness of the findings. After removing
the missing covariates, hypertension, high cholesterol, cardiovascular disease, diabetes, COPD, CKD, cholesterol-lowering, and antidiabetic medication use, there were no significant
associations between CI and the prevalence of frailty, which demonstrated the strong stability of the study results. In subgroup analyses, the association between CI and prevalence of
frailty was significant in all subgroups, with statistically significant interactions in most subgroups, suggesting that CI has good applicability and predictive power across a wide range of
older populations. Subgroup analyses showed a higher prevalence of frailty in men, and in heavy drinkers, suggesting that both groups may be more sensitive to the negative effects of
abdominal fat accumulation. Men tend to store fat in the form of visceral fat, which has higher pro-inflammatory properties18, and heavy alcohol consumption may lead to metabolic
disturbances and nutritional imbalances that exacerbate the risk of frailty19. These findings emphasize the importance of identifying high-risk groups in the context of the individual and
targeting interventions. Recent years have seen a surge in studies on the connection between frailty and metabolic health, body fat distribution, and obesity. Yuan et al. found a U-shaped
association between frailty and both BMI and WC, as well as a high correlation between abdominal obesity and frailty through a systematic review and meta-analysis20. Our findings, which
demonstrated a strong association between CI and the prevalence of frailty, further corroborated this hypothesis. Furthermore, WC has been shown to be a more reliable indicator of older
persons’ risk of frailty than BMI21,22. Our study further demonstrates that WC is more accurate than BMI in both male and female populations. More importantly, CI is more accurate than WC in
predicting frailty in older adults. According to He et al., obesity that was metabolically unhealthy considerably sped up the development of frailty, while obesity that was metabolically
healthy had less of an impact23. Our study also showed that individuals with higher CI are usually accompanied by poorer metabolic health status, increasing the risk of frailty prevalence.
In addition, our study shows a threshold effect and nonlinear association between CI and frailty for the first time, indicating that in both male and female populations, the prevalence of
frailty is significantly higher when the CI is greater than 1.35. This threshold may correspond to a physiologic transition from compensation to imbalance. After a certain level of CI,
abdominal fat may have entered a dysfunctional state characterized by a high release of pro-inflammatory cytokines, adipose tissue hypoxia, and mitochondrial dysfunction24, leading to a
markedly increased systemic inflammatory response. At the same time, muscle mass loss, worsening insulin resistance, hormonal disturbances and elevated levels of oxidative stress are more
pronounced25. Thus, when the CI exceeds the threshold of 1.35, the above pathologic processes may act synergistically to accelerate the onset of frailty. Although this threshold may be
variable in different populations, our findings suggest that CI has potential stratification significance in identifying at-risk individuals. Abdominal fat accumulation raises the risk of
frailty through a number of pathophysiologic mechanisms. One metabolically active tissue that can secrete a number of pro-inflammatory factors, including interleukin-6 and tumor necrosis
factor-alpha, is abdominal fat. These factors cause a systemic, chronic, low-grade inflammation that speeds up the loss of muscle mass and strength, which leads to the development of
frailty26. One of the primary causes of weakness is believed to be this inflammatory condition. People who have a high CI are more likely to have larger reserves of belly fat and are more
vulnerable to the harmful consequences of the inflammatory response. In addition to affecting muscle mass, this persistent low-grade inflammation may hasten the deterioration of other
systems by causing oxidative stress27. The development of insulin resistance is intimately associated with obesity, which in turn directly contributes to metabolic illnesses including
diabetes and hyperlipidemia, which in turn hasten the onset of frailty28. Because abdominal fat is accurately reflected by CI, we found that CI was a better predictor of frailty than BMI in
this study. Additionally, abdominal obesity is linked to a number of hormonal imbalances, such as abnormalities in leptin29, insulin-like growth factor30, and sex hormone-binding globulin31.
Obese people tend to have lower levels of IGF-1 and increased leptin resistance32, which may worsen the condition of frailty. These hormones have significant impacts on muscle mass and bone
strength in addition to being strongly linked to energy metabolism and fat distribution. Also, abdominal obesity is strongly associated with cardiovascular disease risk. By causing harm to
the cardiovascular system, higher CI may hasten the onset of frailty33. Through the indirect effects of decreased physical activity, changed dietary patterns, and heightened chronic
inflammation, excessive obesity is frequently linked to higher levels of psychological issues like anxiety and depression34, which may hasten the onset of frailty35. The ROC analysis in this
study found that CI was a better predictor of frailty than BMI and WC in men and relatively weaker in women. The likely reason for this is that men are more likely to accumulate visceral
fat18, and elevated CI tends to directly reflect abnormal accumulation of visceral fat, which in turn leads to a more pronounced systemic inflammatory response and metabolic disturbances,
mechanisms that are strongly associated with the development of frailty. In contrast, women more commonly exhibit increased subcutaneous fat, which has lower metabolic activity and
inflammatory potential, and CI may not adequately reflect the underlying risk of frailty in women. In addition, estrogen levels in women may be protective against inflammation and fat
distribution36, thus weakening the association between CI and frailty. This result suggests that the moderating role of gender factors on fat distribution patterns and pathophysiologic
mechanisms should be considered when assessing the risk of frailty. Because the study is based on NHANES data, which has a large and nationally representative sample size, its conclusions
are more reliable. The reliability of the results was improved by the study’s adjustment for a number of possible confounders, such as age, gender, race, and lifestyle characteristics. The
results’ robustness was further supported by subgroup analyses, which revealed a strong correlation between CI and frailty in all groups. The study also had limitations. As there is no
uniform international classification standard for CI. This study uses quartiles for grouping, aiming to achieve internal risk stratification based on the study sample. However, the external
comparability of this method is limited. In the future, large-scale cohort studies should be relied upon to establish normative ranges and clinical classification boundaries for CI to
enhance its practical value in disease screening and risk prediction. The data came from a cross-sectional survey, so it was not possible to prove a causal relationship between CI and
frailty; further longitudinal research is needed to confirm this; even after controlling for a number of variables, there may be potential confounders (e.g., genetic factors, etc.) that were
missed; the study population was an older U.S. population, and further validation is needed to determine whether the findings apply to other regions or ethnicities. CONCLUSION This study
showed a strong positive correlation between CI and frailty in older Americans, emphasizing the significance of taking metabolic parameters into account when developing prevention and
treatment plans for frailty. Future research should examine how well strategies to lower CI and slow the onset of frailty work. These findings demonstrate the potential of CI as a screening
and management tool for frailty; however, larger prospective studies are needed for further confirmation. DATA AVAILABILITY Data is provided within the manuscript or supplementary
information files. REFERENCES * Kwak, D. & Thompson, L. V. Frailty: past, present, and future?. _Sports Med. Health Sci._ 3, 1 (2021). Article PubMed Google Scholar * Doody, P., Lord,
J. M., Greig, C. A. & Whittaker, A. C. Frailty: pathophysiology, theoretical and operational definition(s), impact, prevalence, management and prevention, in an increasingly
economically developed and ageing world. _Gerontology_ 69, 927 (2023). Article PubMed Google Scholar * Dent, E. et al. Recent developments in frailty identification, management, risk
factors and prevention: A narrative review of leading journals in geriatrics and gerontology. _Ageing Res. Rev._ 91, 102082 (2023). Article PubMed Google Scholar * Afonso, C. et al.
Frailty status is related to general and abdominal obesity in older adults. _Nutr. Res._ 85, 21 (2021). Article CAS PubMed Google Scholar * Neeland, I. J. et al. Visceral and ectopic
fat, atherosclerosis, and cardiometabolic disease: a position statement. _Lancet Diabetes Endo._ 7, 715 (2019). Article Google Scholar * Valdez, R., Seidell, J. C., Ahn, Y. I. & Weiss,
K. M. A new index of abdominal adiposity as an indicator of risk for cardiovascular disease. A cross-population study. _Int. J. Obes. Relat. Metab. Disord._ 17, 77 (1993). CAS PubMed
Google Scholar * Zhang, Y., Zeng, Q., Li, X., Zhu, P. & Huang, F. Application of conicity index adjusted total body fat in young adults-a novel method to assess metabolic diseases risk.
_Sci. Rep. U.K._ 8, 10093 (2018). Article ADS Google Scholar * Wu, L. D., Kong, C. H., Shi, Y., Zhang, J. X. & Chen, S. L. Associations between novel anthropometric measures and the
prevalence of hypertension among 45,853 adults: A cross-sectional study. _Front. Cardiovasc. Med._ 9, 1050654 (2022). Article PubMed PubMed Central Google Scholar * Zhang, J. et al.
Associations between novel anthropometric indices and the prevalence of gallstones among 6,848 adults: a cross-sectional study. _Front. Nutr._ 11, 1428488 (2024). Article PubMed PubMed
Central Google Scholar * Long, T., Cheng, B. & Zhang, K. Abdominal obesity as assessed by anthropometric measures associates with urinary incontinence in females: findings from the
national health and nutrition examination survey 2005–2018. _BMC Womens Health_ 24, 212 (2024). Article PubMed PubMed Central Google Scholar * Dai, X., Chang, Y. & Hou, Y.
Associations between the conicity index and kidney stone disease prevalence and mortality in American adults. _Sci. Rep. U.K._ 15, 902 (2025). Article CAS Google Scholar * Searle, S. D.,
Mitnitski, A., Gahbauer, E. A., Gill, T. M. & Rockwood, K. A standard procedure for creating a frailty index. _BMC Geriatr._ 8, 24 (2008). Article PubMed PubMed Central Google Scholar
* Hakeem, F. F., Bernabé, E. & Sabbah, W. Association between oral health and frailty among American older adults. _J. Am. Med. Dir. Assoc._ 22, 559 (2021). Article PubMed Google
Scholar * Rockwood, K., Andrew, M. & Mitnitski, A. A comparison of two approaches to measuring frailty in elderly people. _J Gerontol. A-Biol._ 62, 738 (2007). Article Google Scholar
* Rattan, P. et al. Inverse association of telomere length with liver disease and mortality in the US population. _Hepatol. Commun._ 6, 399 (2022). Article CAS PubMed Google Scholar *
Jia, S., Huo, X., Sun, L., Yao, Y. & Chen, X. The association between the weight-adjusted-waist index and frailty in US older adults: a cross-sectional study of NHANES 2007–2018. _Front.
Endocrinol._ 15, 1362194 (2024). Article Google Scholar * Krebs-Smith, S. M. et al. Update of the healthy eating index: HEI-2015. _J. Acad. Nutr. Diet._ 118, 1591 (2018). Article PubMed
PubMed Central Google Scholar * Nauli, A. M. & Matin, S. Why do men accumulate abdominal visceral fat?. _Front. Physiol._ 10, 1486 (2019). Article PubMed PubMed Central Google
Scholar * McLean, C., Ivers, R., Antony, A. & McMahon, A. T. Malnutrition, nutritional deficiency and alcohol: A guide for general practice. _Aust. J. Gen. Pract._ 53, 173 (2024).
Article PubMed Google Scholar * Yuan, L., Chang, M. & Wang, J. Abdominal obesity, body mass index and the risk of frailty in community-dwelling older adults: a systematic review and
meta-analysis. _Age Ageing_ 50, 1118 (2021). Article PubMed Google Scholar * Crow, R. S. et al. Association of obesity and frailty in older adults: NHANES 1999–2004. _J Nutr. Health
Aging_ 23, 138 (2019). Article CAS PubMed PubMed Central Google Scholar * Liao, Q., Zheng, Z., Xiu, S. & Chan, P. Waist circumference is a better predictor of risk for frailty than
BMI in the community-dwelling elderly in Beijing. _Aging Clin. Exp. Res._ 30, 1319 (2018). Article PubMed Google Scholar * He, D. et al. Associations of metabolic heterogeneity of obesity
with frailty progression: Results from two prospective cohorts. _J Cachexia Sarcopeni_ 14, 632 (2023). Article Google Scholar * Unamuno, X. et al. Adipokine dysregulation and adipose
tissue inflammation in human obesity. _Eur. J. Clin. Invest._ 48, e12997 (2018). Article PubMed Google Scholar * Mlinar, B. & Marc, J. New insights into adipose tissue dysfunction in
insulin resistance. _Clin. Chem. Lab. Med._ 49, 1925 (2011). Article CAS PubMed Google Scholar * Popko, K. et al. Proinflammatory cytokines Il-6 and TNF-α and the development of
inflammation in obese subjects. _Eur. J. Med. Res._ 15, 120 (2010). Article PubMed PubMed Central Google Scholar * Zhang, X., Li, H., Chen, L., Wu, Y. & Li, Y. NRF2 in age-related
musculoskeletal diseases: Role and treatment prospects. _Genes Dis_ 11, 101180 (2024). Article CAS PubMed Google Scholar * Fryk, E. et al. Hyperinsulinemia and insulin resistance in the
obese may develop as part of a homeostatic response to elevated free fatty acids: A mechanistic case-control and a population-based cohort study. _EBioMedicine_ 65, 103264 (2021). Article
CAS PubMed PubMed Central Google Scholar * Obradovic, M. et al. Leptin and obesity: role and clinical implication. _Front. Endocrinol._ 12, 585887 (2021). Article Google Scholar *
Al-Samerria, S. & Radovick, S. Exploring the therapeutic potential of targeting GH and IGF-1 in the management of obesity: insights from the interplay between these hormones and
metabolism. _Int. J. Mol. Sci._ 24, 11 (2023). Article Google Scholar * Haffner, S. M. Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and
clinical correlation. _Int. J. Obes. Relat. Metab. Disord._ 24, S56 (2000). Article CAS PubMed Google Scholar * Zhong, W. et al. Obesity and endocrine-related cancer: The important role
of IGF-1. _Front. EndocrinoL._ 14, 1093257 (2023). Article Google Scholar * Wang, J. et al. Sex differences in the associations between relative fat mass and all-cause and cardiovascular
mortality: A population-based prospective cohort study. _Nutr. Metab. Cardiovas._ 34, 738 (2024). Article Google Scholar * Zhang, Y. et al. Type 2 diabetes mellitus modifies and mediates
the association between the visceral adiposity index and depression: A cross-sectional study using NHANES 2005–2018 data. _J. Affect Disorders_ 368, 749 (2025). Article PubMed Google
Scholar * Fulton, S., Décarie-Spain, L., Fioramonti, X., Guiard, B. & Nakajima, S. The menace of obesity to depression and anxiety prevalence. _Trends Endocrin Met_ 33, 18 (2022).
Article CAS Google Scholar * Escobar-Morreale, H. F., Alvarez-Blasco, F., Botella-Carretero, J. I. & Luque-Ramírez, M. The striking similarities in the metabolic associations of
female androgen excess and male androgen deficiency. _Hum. Reprod._ 29, 2083 (2014). Article CAS PubMed Google Scholar Download references ACKNOWLEDGEMENTS The authors express gratitude
to all participants and investigators of the NHANES. FUNDING The Scientific Research Program of Sichuan medical and health care promotion institute,KY2022SJ0396 AUTHOR INFORMATION AUTHORS
AND AFFILIATIONS * Department of Sports Medicine, Sichuan Provincial Orthopedics Hospital, Chengdu, China Jie Xu, Jiaming Cui & Xiaobing Luo * Department of Emergency Medicine, Nanchong
Hospital of Traditional Chinese Medicine, Nanchong, China Meng Chen Authors * Jie Xu View author publications You can also search for this author inPubMed Google Scholar * Meng Chen View
author publications You can also search for this author inPubMed Google Scholar * Jiaming Cui View author publications You can also search for this author inPubMed Google Scholar * Xiaobing
Luo View author publications You can also search for this author inPubMed Google Scholar CONTRIBUTIONS J.X. and M.C. designed the research. J.X. collected, analyzed the data, and drafted the
manuscript. JM.C., and XB. L. revised the manuscript. All authors contributed to the article and approved the submitted version. CORRESPONDING AUTHOR Correspondence to Xiaobing Luo. ETHICS
DECLARATIONS COMPETING INTERESTS The authors declare no competing interests. ADDITIONAL INFORMATION PUBLISHER’S NOTE Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations. SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION. RIGHTS AND PERMISSIONS OPEN ACCESS This article is licensed under a Creative Commons
Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission
under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by
statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
http://creativecommons.org/licenses/by-nc-nd/4.0/. Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Xu, J., Chen, M., Cui, J. _et al._ Association between conicity index and
frailty in older Americans: the NHANES cross-sectional study, 2007–2018. _Sci Rep_ 15, 17857 (2025). https://doi.org/10.1038/s41598-025-02455-4 Download citation * Received: 22 January 2025
* Accepted: 13 May 2025 * Published: 22 May 2025 * DOI: https://doi.org/10.1038/s41598-025-02455-4 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this
content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative
KEYWORDS * Conicity index * Obesity * Cross-sectional study * Frailty * NHANES